Cargando…
Treatment for Severe Lupus Nephritis: A Cost-Effectiveness Analysis in China
Background: Lupus nephritis (LN) is the most common secondary glomerular diseases that will cause end-stage renal disease (ESRD) and renal-related death. The cost-effectiveness of various treatments for LN recommended by official guidelines has not been investigated in China. Our study is to evaluat...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450585/ https://www.ncbi.nlm.nih.gov/pubmed/34552479 http://dx.doi.org/10.3389/fphar.2021.678301 |